Part 11
Land transport secondary legislation
Regulations
167AABMinisters may appoint independent experts for purposes of section 167AAA
The Minister of Transport, the Minister of Police, and the Science Minister (the Ministers) may from time to time appoint 1 or more independent experts to advise the Ministers on matters relating to setting and amending high-risk blood concentration levels and tolerance blood concentration levels for qualifying drugs under section 167AAA.
The independent experts appointed under subsection (1) must together have appropriate expertise in relevant medical and scientific fields, including pharmacology and toxicology.
The function of the independent experts is—
- to carry out medical and scientific evaluations of qualifying drugs; and
- to advise the Ministers on—
- the specific effects of qualifying drugs, including the pharmacological, psychoactive, and toxicological effects; and
- the appropriate high-risk levels and tolerance levels for qualifying drugs in accordance with subsections (4) and (5).
- the specific effects of qualifying drugs, including the pharmacological, psychoactive, and toxicological effects; and
In advising the Ministers on the appropriate high-risk level for a qualifying drug, the independent experts must take into account—
- the specific effects of the qualifying drug and the medical and scientific evaluations of the drug carried out under subsection (3)(a); and
- that the high-risk level specified for a qualifying drug should, as far as practicable, be a blood concentration level that, to the best of the independent experts’ knowledge, is likely to impair a person’s driving; and
- the high-risk levels specified, at the time of advising the Ministers, in Part 1 of Schedule 5 for other listed qualifying drugs and, in particular (where possible), for drugs with similar effects.
In advising the Ministers on the appropriate tolerance level for a qualifying drug, the independent experts must take into account—
- the specific effects of the qualifying drug and the medical and scientific evaluations of the drug carried out under subsection (3)(a); and
- that the tolerance level specified for a qualifying drug should, as far as practicable, be a blood concentration level that, to the best of the independent experts’ knowledge,—
- is likely to indicate that a person has recently used the drug; and
- is unlikely to be exceeded if the person has such a low level of the drug in their blood (whether due to passive exposure or otherwise) that their driving is unlikely to be impaired; and
- is likely to indicate that a person has recently used the drug; and
- for a qualifying drug that is a prescription medicine, the maximum dose of the prescription medicine that is generally prescribed; and
- the tolerance levels specified, at the time of advising the Ministers, in Part 2 of Schedule 5 for other listed qualifying drugs and, in particular (where possible), for drugs with similar effects.
Notes
- Section 167AAB: inserted, on , by section 37 of the Land Transport (Drug Driving) Amendment Act 2022 (2022 No 5).